Financial reviews and presentations

Orion will publish Financial Statement Release for 2022 on Thursday, 9 February 2023. The report, related presentation material and link to webcast are available here after publishing.

Read more

Liisa Hurme, new President and CEO: A time of strong growth for Orion

AGM 2023

Possible requests from the shareholders to have a matter dealt with by Orion Corporation’s Annual General Meeting 2023 must be submitted to the Board of Directors of Orion Corporation no later than Monday, 16 January 2023.

Read more

Financial Statements

Orion Group's Financial Statement documents are available here.

Read more

Orion acquires Inovet's animal health business

AGM 2022

The Annual General Meeting of Orion Corporation was held on Wednesday 23 March 2022. The decisions and related material are available here.

Read more

Corporate Governance Statement

The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.

Read more

CMD 2021

Orion’s virtual Capital Markets Day 2021 was held on 26 May 2021. Presentations and webcast from the event are available here.

Read more

Share information

Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.

Read more

Major shareholders by votes

Monthly updated list of Orion's major shareholders by votes.

Read more

Orion's R&D Pipeline

Read more

Orion Executive Management Board

The members of the Board of Directors

Our approach to corporate responsibility

Orion aims to grow faster than the pharmaceutical market

Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.

Read more

Investing benefits both investors and society

Responsibility is one incentive when retail investors seek investments. Pharmaceuticals and healthcare is one of the most interesting sectors.

Read more